Coya Therapeutics, Inc. (COYA) Misses Q2 EPS by 49c
Tweet
Share
E-mailGet Alerts COYA Hot Sheet
Join SI Premium – FREE
Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.36), $0.49 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $163.62 thousand.
For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- UBS Resumes Flagstar Bank (FLG) at Buy
- Snail Games launches ARK titles, expects $11M revenue recognition
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
